Hydroxythiohomo sildenafil
CAS: 479073-82-0
Ref. 3D-FH24512
1mg | 440,00 € | ||
2mg | 626,00 € | ||
5mg | 969,00 € | ||
10mg | 1.403,00 € | ||
25mg | 2.806,00 € |
Información del producto
- 5-[2-Ethoxy-5-[[4-(2-hydroxyethyl)-1-piperazinyl]sulfonyl]phenyl]-1,6-dihydro-1-methyl-3-propyl-7H-pyrazolo[4,3-d]pyrimidine-7-thion e4-[[3-(4,7-Dihydro-1-methyl-3-propyl-7-thioxo-1H-pyrazolo[4,3-d]pyrimidin-5-yl)-4-ethoxyphenyl]sulfonyl]-1-piperazin
- 1-Piperazineethanol, 4-[[3-(4,7-dihydro-1-methyl-3-propyl-7-thioxo-1H-pyrazolo[4,3-d]pyrimidin-5-yl)-4-ethoxyphenyl]sulfonyl]-
- Hydroxythiohomosildenafil
- 5-(2-ethoxy-5-(4-(2-hydroxyethyl)piperazin-1-ylsulfonyl)phenyl)-1-methyl-3-propyl-1H-pyrazolo[4,3-d]pyrimidine-7(6H)-thione
- 7H-Pyrazolo[4,3-d]pyrimidine-7-thione, 5-[2-ethoxy-5-[[4-(2-hydroxyethyl)-1-piperazinyl]sulfonyl]phenyl]-1,6-dihydro-1-methyl-3-propyl-
- 5-[2-Ethoxy-5-[[4-(2-hydroxyethyl)-1-piperazinyl]sulfonyl]phenyl]-1,6-dihydro-1-methyl-3-propyl-7H-pyrazolo[4,3-d]pyrimidine-7-thione
Hydroxythiohomo sildenafil is a pharmaceutical drug that belongs to the class of PDE-5 inhibitors. It is a metabolite of sildenafil and has been shown to have similar effects as its parent compound, but with improved absorption. This drug inhibits the breakdown of cGMP by phosphodiesterase type 5 (PDE-5) in the corpus cavernosum, leading to an increase in penile erection. Hydroxythiohomo sildenafil has been shown to improve erectile function in people with diabetes mellitus and appears to be effective for treating erectile dysfunction. Hydroxythiohomo sildenafil is currently under development for the treatment of pulmonary arterial hypertension.
Propiedades químicas
Consulta técnica sobre: 3D-FH24512 Hydroxythiohomo sildenafil
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.